LifeStance sells 22.25M shares in secondary offering; buys back 2M

LifeStance Health Group, Inc.

Selling stockholders sold 22,250,000 shares; company repurchased 2,000,000 shares at same price per share.
Company received no proceeds from the offering; all proceeds went to selling stockholders named in Schedule II.
Offering closed September 11, 2026; underwriter was Barclays Capital Inc.
Repurchase reduces outstanding share count; no underwriting compensation was paid on repurchased shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.